Position in ENTA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,567,070
-$770,081 QoQ
Shares Held
203,252
-4.0% QoQ
Ownership
0.699%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 75%
Shared 13%
None 12%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ENTA ranks #116 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,567,070 | 203,252 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,337,151 | 211,614 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,232,712 | 270,068 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,098,957 | 277,640 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,558,306 | 282,302 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,708,357 | 297,106 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,014,604 | 194,460 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,673,932 | 129,062 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,304,407 | 189,256 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,689,685 | 179,563 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,197,728 | 196,753 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,532,456 | 445,442 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $21,784,580 | 538,689 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $25,286,688 | 543,566 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $26,447,369 | 509,878 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $24,755,722 | 523,709 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $42,246,753 | 593,520 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $44,997,967 | 601,738 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $34,703,297 | 610,866 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $28,377,119 | 644,788 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $28,975,302 | 587,496 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $28,258,404 | 671,221 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $32,046,595 | 700,013 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $35,992,435 | 716,838 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $36,798,319 | 715,503 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||